In 2017, IDF global diabetes map (8th Edition) was released!

Release time: 2017-12-20 14:03:30 Page views: 400

2017-12-20 biological and xenotransplantation
The day before, the International Diabetes Federation (IDF) released the 8th global diabetes map.

The new map shows that there are 425 million diabetic patients worldwide, and it is expected that by 2045, there will be nearly 700 million diabetic patients.

According to the new version of the map, every 11 adults in 1 diabetic patients:

The number of undiagnosed adult diabetic patients worldwide is 212 million, and 1 out of 2 adult diabetic patients are undiagnosed.

1/6 fetus is affected by hyperglycemia during pregnancy:

More than 100 million of the world‘s children and adolescents suffer from type 1 diabetes:


A global survey of diabetes

In 2017 and 2045 diabetes prevalence of all regions of the world and the growth rate (20-79 years old)


The incidence of diabetes in all regions of the region has its own characteristics, but the overall incidence of diabetes is serious.

For example, in Africa, more than 2/3 of diabetic patients have not been diagnosed;

The number of children and adolescents with type 1 diabetes is the largest in the European region.

It is expected that by 2045, diabetes patients in the Middle East and North Africa will increase by 72%;

North America and the Caribbean region has the highest prevalence of diabetes in the world (11%).

By 2045, diabetic patients in South and China will increase by 62%.

Diabetes in the Western Pacific is the highest, reaching 158 million.

Next to South East Asia, there are 82 million adult diabetic patients.

It is estimated that in 2017, 7.3% of the 20-79 year olds had impaired glucose tolerance, and the number reached 352 million 100 thousand. Most of the patients (72.3%) came from low - and middle - income countries. By 2045, this number will reach 587 million, accounting for 8.3% of the 20-79 year olds.

Adult diabetes and the corresponding number of the top ten national health expenditures (2017).
It is noteworthy that the number of adult diabetes (20-79 years old) in China is 114 million, and is still the largest number of diabetes in the world.

The number of children and adolescents with type 1 diabetes (20 years old) was ten (2017), including China.

The president of the International Diabetes Federation Shaukat Sadikot says there are nearly 500 million of the world‘s diabetic patients worldwide. In particular, low - and middle - income countries bear almost 80% of the burden of diabetes.

Unhealthy diet and sedentary lifestyle further lead to an increase in the prevalence of obesity and diabetes, and urge all regions to control the prevalence of diabetes based on local conditions.

[heterologous transplantation of vs diabetes]

Although diabetes is a worldwide problem, it has not been solved perfectly. But in China, there are such a group of scientists, who devoted more than twenty years of effort to the research and development of swine islet xenotransplantation for the treatment of diabetes.

(Professor Wang Wei)

As a pioneer of this technology, the research team leader, Professor Wang Wei of Central South University Xiangya Hospital has experienced a long course of scientific research. From the cultivation of the donor to the extraction of the islets, and to the technical breakthrough of the clinical application, thousands of days and nights have achieved the results today.

In September 8, 2017, Hunan province will organize medical disciplines in the national top experts, Changsha of Third Xiangya Hospital of Central South University and Hunan sainuo Polytron Technologies Inc completed "biological neonatal porcine islet transplantation in the treatment of type 1 diabetes clinical research" evaluation.

(expert evaluation will be on the scene)

The expert group review review, agreed that: twenty years after the project team to persevere, for the first time in the world established donor culture of porcine islet extraction and clinical application of integrated technology system, has reliable biocompatibility, made the islet xenograft the best curative effect, can be used in the treatment of type 1 diabetes, reached the international advanced level.

The expert group recommends that the technology of heterologous islet transplantation for the treatment of diabetes is included in the three category of medical technology management, and the corresponding clinical application technical specifications shall be worked out so as to promote the clinical application of the technology.